No Data
No Data
NETRAMARK SIGNS CONTRACT WITH PHARMACEUTICAL COMPANY TO DELIVER CLINICAL TRIAL INSIGHTS REGARDING...
NetraMark Presenting New Data Showing Ability of Its Proprietary NetraAI Clinical Trial Solution in PD Insights
NetraMark Holdings Inc. (AIAI.CN), a generative AI software player in clinical trial analytics, on Monday announced the presentation of new data showing the ability of its NetraAI clinical trial solut
NETRAMARK'S AI-BASED CLINICAL SOLUTION IDENTIFIES PARKINSON'S DISEASE SUBTYPES LINKED BY MITOCHON...
NETRAMARK'S AI-BASED TECHNOLOGY IDENTIFIES SIGNIFICANT DRIVERS OF EFFICACY AND PLACEBO RESPONSES...
NETRAMARK ANNOUNCES LAUNCH OF THE NETRA AI LAB
NetraMark Up 8.6% After Reporting Third Contract With Biopharmaceutical Firm
NetraMark Holdings Inc. (AIAI.CN) on Tuesday rose 8.6% on last look after reporting a third contract with a large publicly listed biopharmaceutical company to enhance insights of clinical trials. Unde